Filter your experience: all

Show me information for: Young people Adults Parents Teachers Doctors All What are these?


Down to content

ORBIT Study: Fantastic behavioural therapy research opportunity for 9-17 year olds

Posted on 13 November 2017 by Helen Robbins


Researchers at The University of Nottingham are working with the NHS to plan a new study for children and young people with tics.

Children and young people who join the study will be placed into one of two groups. Each group will be given an online treatment to help tics, but the content of the two treatments differs slightly. You will only receive one of the treatments. The researchers think both treatments are good but want to find out which treatment is best at helping children and young people with tics. The treatment is free, takes 10-weeks to complete, and is conducted over the internet, using a secure platform. This means it can be done at home at a time that suits you!

Watch this great short animation about the ORBIT trial

The researchers at Nottingham are currently finalising the design of the study and we will send out more details in early 2018.  By registering your interest at, you will be the first to be given the opportunity to potentially take part in this study.

If people in the Leicester area are interested in joining in the Orbit study can they contact

Rebekah Pole (Clinical Studies Officer) from the Leicestershire Partnership NHS Trust

The study will start in April 2018. To be eligible for the study you have to be living in England and be aged 9-17 years-old.

You can visit the ORBIT website for more information

To register your interest in the study click on this link where you will be asked to provide your contact details:



If you would like to be informed of other Research studies please join the  Tourettes Action Research Participant registry by emailing

Return to news








This website may use cookies to provide an improved experience. You can refuse these cookies by changing your browser settings.
To remove this message, click here to accept cookies.